Quarterly report pursuant to Section 13 or 15(d)

Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Tables)

v2.4.1.9
Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Tables)
 3 Months Ended
Mar. 31, 2015
Accounting Policies [Abstract]  
Schedule of Franchisor Disclosure [Table Text Block]
   
Three Months Ended
March 31,
 
   
2015
   
2014
 
Clinics open at beginning of period
    246       175  
Clinics opened during the period
    13       18  
Clinics closed during the period
    (6 )     (1 )
Clinics in operation at the end of the period
    253       192  
                 
Clinics sold but not yet operational
    254       263  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
   
Three Months Ended
March 31,
 
   
2015
   
2014
 
             
Net loss
  $ (1,903,723 )   $ (127,894 )
                 
Weighted average common shares outstanding - basic
    9,662,502       4,811,561  
Effect of dilutive securities:
               
Stock options
    -       -  
Shares issuable on conversion of preferred stock
    -       -  
Weighted average common shares outstanding - diluted
    9,662,502       4,811,561  
                 
Basic and diluted loss per share
  $ (0.20 )   $ (0.03 )
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
   
Three Months Ended
March 31,
 
   
2015
   
2014
 
Unvested restricted stock
    522,356       125,159  
Stock options
    366,995       198,915  
Warrants
    90,000       -